The Next Domino: Automation, AI, and touchless safety case processing

Publication
Article
Pharm Exec E-BooksPharm Exec E-Books-03-08-2021
Volume Sponsored eBook
Issue 2

With the increasing volumes of adverse event reports and stagnant budgets, the time is now for a revolutionary change in drug and device safety case management. A robust management process is necessary for identifying and evaluating adverse events (AE) and reporting them properly to regulators.

Related Content